AGP Picks
View all

PRISM MarketView Highlights Four Small Caps Working on Alzheimer’s Disease for National Alzheimer’s Disease Awareness Month

News originally published by

GlobeNewswire

Feature reviews this week’s CTAD 2026 readouts and where four small-cap companies stand in pills, immunotherapy, agitation treatment and brain testing

National Alzheimer's Disease Awareness Month graphic with a purple awareness ribbon and the PRISM MarketView logo

NEW YORK, Nov. 19, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView, a financial media platform covering small-cap public companies through 27 thematic indexes, today published a National Alzheimer’s Disease Awareness Month feature on four small-cap companies working on Alzheimer’s disease, from treatment to testing.

The feature follows this week’s Clinical Trials on Alzheimer’s Disease (CTAD) conference in Boston, where readouts pointed in different directions. Biogen reported that the lowest dose of diranersen slowed decline by 38% at two years in an open-label extension, while Priavoid’s PRI-002 missed its efficacy endpoint and Lilly is ending development of mevidalen.

Annovis Bio (NYSE: ANVS) expects six-month topline results from its Phase 3 DUET-AD trial of once-daily buntanetap in March 2027, after an independent safety board recommended for a second time that the study continue. AC Immune (NASDAQ: ACIU) reported antibody responses at every dose level of its ACI-24 immunotherapy, partnered with Takeda, with no ARIA-E brain swelling across 74 patients.

IGC Pharma (NYSE American: IGC) completed dosing in its 170-participant CALMA trial for agitation in Alzheimer’s dementia, with topline results expected in December 2026 or January 2027, and Firefly Neuroscience (NASDAQ: AIFF) has its FDA-cleared Evoke EEG System in use at more than 85 U.S. clinical sites.

Read the full article on PRISM MarketView: https://prismmarketview.com/national-alzheimers-disease-awareness-month-what-ctad-2026-showed-and-where-four-small-caps-stand/

About PRISM MarketView

PRISM MarketView is a financial media and index publishing platform for investors seeking small-cap opportunities. Since 2020, PRISM has covered emerging growth companies through daily news, analysis and 27 thematic small-cap indexes spanning biotech, medtech, AI, energy and more. Learn more at prismmarketview.com.

Follow PRISM MarketView on X, LinkedIn, Instagram, TikTok and YouTube.

PRISM MarketView does not provide investment advice.

Media Contact

info@prismmarketview.com

646-863-6341

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cf04a9da-2fc5-48bd-969e-ef11bf8d7fca


Primary Logo

National Alzheimer's Disease Awareness Month

PRISM MarketView highlights four small caps working on Alzheimer's disease for National Alzheimer's Disease Awareness Month.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

New Mexico Industry Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.